Synopsis of recent research by authors named "Xuanming Xu"
- Xuanming Xu's recent research focuses on developing advanced electrochemical biosensors for the early detection of critical biomarkers and drugs, particularly human epididymis protein 4 (HE4) for ovarian cancer and imatinib for leukemia treatment.
- Xu's studies highlight the innovation of using signal amplification techniques, such as functionalized metal-organic frameworks and acetylene black, to enhance the sensitivity and selectivity of electrochemical sensors, providing significant benefits in therapeutic drug monitoring.
- The author also explores the application of molecularly imprinted polymers for selective extraction and detection of other pharmaceuticals, indicating a broader commitment to improve clinical analysis techniques for various medical compounds.
